SCHEMBL6766022

SCHEMBL6766022

CCCS(=O)(=O)NCc1ccc(OC(C)CNS(=O)(=O)CCC)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.41
ACACB O00763 1/20 0.41
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
GRIA4 P48058 1/20 0.38
MTNR1A P48039 2/20 0.38
MTNR1B P49286 2/20 0.38
JAK2 O60674 1/20 0.37
FLT3 P36888 1/20 0.37
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
MAPT P10636 1/20 0.36
ALOX15 P16050 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6475845 0.96 GRIA4 (0.41) TP53ACACBHTTSMN1; SMN2LMNA
SCHEMBL6480391 0.90 TP53 (0.40) TP53ACACBHTTSMN1; SMN2LMNA
SCHEMBL6482324 0.87 GRIA4 (0.46) TP53ACACBTSHRGRIA4MTNR1A
SCHEMBL6475840 0.86 CA2 (0.41) TP53ACACBHTTSMN1; SMN2LMNA
SCHEMBL6482788 0.84 GRIA4 (0.39) ACACBSMN1; SMN2LMNAGRIA4MTNR1A
SCHEMBL6474720 0.84 GRIA4 (0.39) ACACBSMN1; SMN2LMNAGRIA4MTNR1A
SCHEMBL6475278 0.84 GRIA4 (0.39) ACACBSMN1; SMN2LMNAGRIA4MTNR1A
SCHEMBL6481142 0.84 MTNR1A (0.47) ACACBMTNR1AMTNR1BALDH1A1MAPT
SCHEMBL6766134 0.84 MEN1 (0.42) ACACBTSHRGRIA4MTNR1AMTNR1B
SCHEMBL6475448 0.84 ERCC1 (0.39) GRIA4MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040147612-A1 Sulfonamide derivatives DAVISON JOSHUA ZWICK (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147612-A1 Sulfonamide derivatives GRIN1, GRIN2A, GRIA1 TP53 4866/4885ACACB 3850/4885HTT 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.